Common Stock SEC Reporting - Current
Verified Company Profile 2/15/2017
Contact Info
  • 1111 Main Street
  • Suite 660
  • Vancouver, WA 98660

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Feb 28, 2017 10-Q
CIK 0001175680
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 7 a/o Jan 26, 2017
Company Officers/Contacts
Nader Z, Pourhassan, Ph.D. CEO, President
Michael D. Mulholland CFO, Treasurer, Corporate Secretary
Denis R. Burger, Ph.D. Chief Scientific Officer
Tracie L. Melchior, CPA Director of Accounting
Company Directors
Anthony D. Caracciolo Executive Chairman
Gregory A Gould, CPA
Carl C. Dockery
A. Bruce Montgomery, M.D.
Jordan G. Naydenov
Denis R. Burger, Ph.D.
Nader Z, Pourhassan, Ph.D.
Service Providers
Accounting/Auditing Firm
Warren Averett, LLC
100 South Ashley Drive
Suite 1650
Tampa, FL, 33602
United States
Securities Counsel
Lowenstein Sandler PC
1251 Avenue of the Americas
New York, NY, 10021
United States
Investor Relations Firm
LHA Associates
800 Third Avenue
17th Floor
New York, NY, 10022
United States
CYDY Security Details
Share Structure
Market Value1 $104,627,771 a/o Jun 23, 2017
Authorized Shares 350,000,000 a/o Nov 30, 2016
Outstanding Shares 149,468,244 a/o Mar 31, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 84,065,617 a/o Nov 30, 2016
Par Value No Par Value
Shareholders of Record 568 a/o Jul 31, 2016
Short Selling Data
Short Interest 31,292 (-64.76%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security